Conquest Research, LLC

Futó vizsgálatok

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

  NCT07781657· 2. fázis· Forrás

• Toboroz

  A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

  NCT07717411· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07169578· 3. fázis· Forrás

• Fut, nem toboroz

  A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

  NCT07105488· 2. fázis· Forrás

• Toboroz

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· 3. fázis· Forrás

• Fut, nem toboroz

  PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)

  NCT06750432· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

  NCT05531656· 2. fázis· Forrás

• Fut, nem toboroz

  Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease

  NCT04639050· 1/2. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Alzheimer-kór3 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

  NCT06881836· 2. fázis· Forrás

• Lezárult

  A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

  NCT05686044· 2/3. fázis· Forrás

• Lezárult

  A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

  NCT05357989· 3. fázis· Forrás